Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations
JCO Precision Oncology · 2024
DOI: 10.1200/po.24.00106 ↗Kurz gefasst
Leitlinie in der Zeitschrift JCO Precision Oncology, 2024. Verfasst von N Jewel Samadder und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
PURPOSE The autosomal dominant cancer predisposition disorders hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS) are genetic conditions for which early identification and intervention have a positive effect on the individual and public health. The goals of this study were to determine whether germline genetic screening using exome sequencing could be used to efficiently identify carriers of HBOC and LS. METHODS Participants were recruited from three geographically and racially diverse sites in the United States (Rochester, MN; Phoenix, AZ; Jacksonville, FL). Participants underwent Exome+ sequencing (Helix Inc, San Mateo, CA) and return of results for specific genetic findings: HBOC ( BRCA1 and BRCA1) and LS ( MLH1, MSH2, MSH6, PMS2, and EPCAM). Chart review was performed to collect demographics and personal and family cancer history. RESULTS To date, 44,306 participants have enrolled in Tapestry. Annotation and interpretation of all variants in genes for HBOC and LS resulted in the identification of 550 carriers (prevalence, 1.24%), which included 387 with HBOC (27.2% BRCA1, 42.8% BRCA2) and 163 with LS (12.3% MSH6, 8.8% PMS2, 4.5% MLH1, 3.8% MSH2, and 0.2% EPCAM). More than half of these participants (52.1%) were newly diagnosed carriers with HBOC and LS. In all, 39.2% of HBOC/LS carriers did not satisfy National Comprehensive Cancer Network (NCCN) criteria for genetic evaluation. NCCN criteria were less commonly met in underrepresented minority populations versus self-reported White race (51.5% v 37.5%, P = .028). CONCLUSION Our results emphasize the need for wider utilization of germline genetic sequencing for enhanced screening and detection of individuals who have LS and HBOC cancer predisposition syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology & Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ.
- Center for Individualized Medicine, Mayo Clinic, Rochester, MN.
- Comprehensive Cancer Center, Mayo Clinic, Rochester, MN.
- Division of Gastroenterology & Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN.
- Genetic Counseling Program, Arizona State University, Tucson, AZ.
- Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ.
ORCID-Profile: N Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L Bublitz, Lorelei A Bandel, Sebastian M Armasu, Eric W Klee, Nicholas B Larson, Jessa S Bidwell, Katie L Kunze, Richard J Presutti, Cheryl L Willman, Konstantinos N Lazaridis
Zitieren
APA
Samadder, N. J., Gay, E., Lindpere, V., Bublitz, M. L., Bandel, L. A., Armasu, S. M., Vierkant, R. A., Ferber, M. J., Klee, E. W., Larson, N. B., Kruisselbrink, T. M., Egan, J. B., Kemppainen, J. L., Bidwell, J. S., Anderson, J. L., McAllister, T. M., Walker, T. S., Kunze, K. L., Golafshar, M. A., …, & Lazaridis, K. N. (2024). Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations. JCO Precision Oncology. https://doi.org/10.1200/po.24.00106
Vancouver
Samadder NJ, Gay E, Lindpere V, Bublitz ML, Bandel LA, Armasu SM, et al. Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations. JCO Precision Oncology. 2024. doi:10.1200/po.24.00106
BibTeX
@article{Samadder2024,
author = {Samadder, N Jewel and Gay, Emily and Lindpere, Vanda and Bublitz, Michelle L and Bandel, Lorelei A and Armasu, Sebastian M and Vierkant, Robert A and Ferber, Matthew J and Klee, Eric W and Larson, Nicholas B and Kruisselbrink, Teresa M and Egan, Jan B and Kemppainen, Jennifer L and Bidwell, Jessa S and Anderson, Jennifer L and McAllister, Tammy M and Walker, T'Nita S and Kunze, Katie L and Golafshar, Michael A and Klint, Margaret A and Presutti, Richard J and Bobo, William V and Sekulic, Aleksander and Summer-Bolster, Jolene M and Willman, Cheryl L and Lazaridis, Konstantinos N},
title = {Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations},
journal = {JCO Precision Oncology},
year = {2024},
doi = {10.1200/po.24.00106}
}
EUVIMED